谷歌浏览器插件
订阅小程序
在清言上使用

A Phase I Clinical Trial with a Novel Gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost Regimen

AIDS research and human retroviruses(2014)

引用 0|浏览17
暂无评分
摘要
AIDS Research and Human RetrovirusesVol. 30, No. S1 Vaccine Clinical TrialsA Phase I Clinical Trial with a Novel gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost RegimenAlethea V. Cope, Christiane Moog, Robin J. Shattock, Mira M. Chawda, Justyna Czyzewska-Khan, Pizzoferro Kat, Suzanne Venables, Celine Yan, Marie Williams, Karen Cobb, Mahavir Singh, Wulf Oehlmann, Ayssar Elamin, Dietmar Katinger, Andreas Wagner, Paulatsya Joshi, and David J.M. LewisAlethea V. CopeImperial College, Medicine, London, United KingdomSearch for more papers by this author, Christiane MoogInserm, Strasbourg, FranceSearch for more papers by this author, Robin J. ShattockImperial College, Medicine, London, United KingdomSearch for more papers by this author, Mira M. ChawdaImperial College, Medicine, London, United KingdomSearch for more papers by this author, Justyna Czyzewska-KhanImperial College, Medicine, London, United KingdomSearch for more papers by this author, Pizzoferro KatUniversity of Surrey, Clinical Research Centre, Guildford, United KingdomSearch for more papers by this author, Suzanne VenablesImperial College, Medicine, London, United KingdomSearch for more papers by this author, Celine YanImperial College, Medicine, London, United KingdomSearch for more papers by this author, Marie WilliamsUniversity of Surrey, Clinical Research Centre, Guildford, United KingdomSearch for more papers by this author, Karen CobbUniversity of Surrey, Clinical Research Centre, Guildford, United KingdomSearch for more papers by this author, Mahavir SinghLionex GmbH, Braunschweig, GermanySearch for more papers by this author, Wulf OehlmannLionex GmbH, Braunschweig, GermanySearch for more papers by this author, Ayssar ElaminLionex GmbH, Braunschweig, GermanySearch for more papers by this author, Dietmar KatingerPolymun Scientific GmbH, Klosterneuburg, AustriaSearch for more papers by this author, Andreas WagnerPolymun Scientific GmbH, Klosterneuburg, AustriaSearch for more papers by this author, Paulatsya JoshiUniversity of Surrey, Clinical Research Centre, Guildford, United KingdomSearch for more papers by this author, and David J.M. LewisUniversity of Surrey, Clinical Research Centre, Guildford, United KingdomSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5402.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"A Phase I Clinical Trial with a Novel gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost Regimen." AIDS Research and Human Retroviruses, 30(S1), pp. A187–A188FiguresReferencesRelatedDetails Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Alethea V. Cope, Christiane Moog, Robin J. Shattock, Mira M. Chawda, Justyna Czyzewska-Khan, Pizzoferro Kat, Suzanne Venables, Celine Yan, Marie Williams, Karen Cobb, Mahavir Singh, Wulf Oehlmann, Ayssar Elamin, Dietmar Katinger, Andreas Wagner, Paulatsya Joshi, and David J.M. Lewis.A Phase I Clinical Trial with a Novel gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost Regimen.AIDS Research and Human Retroviruses.Oct 2014.A187-A188.http://doi.org/10.1089/aid.2014.5402.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要